spacer
spacer

PDBsum entry 1imx

Go to PDB code: 
protein ligands metals links
Hormone/growth factor PDB id
1imx

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
56 a.a. *
Ligands
CPQ
Metals
_BR
Waters ×47
* Residue conservation analysis
PDB id:
1imx
Name: Hormone/growth factor
Title: 1.8 angstrom crystal structure of igf-1
Structure: Insulin-like growth factor 1a. Chain: a. Synonym: igf-1. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: igf-1. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.82Å     R-factor:   0.245     R-free:   0.258
Authors: F.F.Vajdos,M.Ultsch,M.L.Schaffer,K.D.Deshayes,J.Liu,N.J.Skelton, A.M.De Vos
Key ref:
F.F.Vajdos et al. (2001). Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions. Biochemistry, 40, 11022-11029. PubMed id: 11551198 DOI: 10.1021/bi0109111
Date:
11-May-01     Release date:   05-Sep-01    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
P05019  (IGF1_HUMAN) -  Insulin-like growth factor 1 from Homo sapiens
Seq:
Struc:
195 a.a.
56 a.a.
Key:    Secondary structure  CATH domain

 

 
DOI no: 10.1021/bi0109111 Biochemistry 40:11022-11029 (2001)
PubMed id: 11551198  
 
 
Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions.
F.F.Vajdos, M.Ultsch, M.L.Schaffer, K.D.Deshayes, J.Liu, N.J.Skelton, A.M.de Vos.
 
  ABSTRACT  
 
Despite efforts spanning considerably more than a decade, a high-resolution view of the family of proteins known as insulin-like growth factors (IGFs) has remained elusive. IGF-1 consists of three helical segments which are connected by a 12-residue linker known as the C-region. NMR studies of members of this family reveal a dynamic structure with a topology resembling insulin but little structural definition in the C-region. We have crystallized IGF-1 in the presence of the detergent deoxy big CHAPS, and determined its structure at 1.8 A resolution by multiwavelength anomalous diffraction, exploiting the anomalous scattering of a single bromide ion and six of the seven sulfur atoms of IGF-1. The structure reveals a well-defined conformation for much of the C-region, which extends away from the core of IGF-1 and has residues known to be involved in receptor binding prominently displayed in a type II beta-turn. In the crystal, these residues form a dimer interface, but analytical ultracentrifugation experiments demonstrate that at physiological concentrations IGF-1 is monomeric. A single detergent molecule contacts residues known to be important for IGF-1 binding protein (IGFBP) interactions. Biophysical and biochemical data show that the detergent binds to IGF-1 specifically and blocks binding of IGFBP-1 and IGFBP-3.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20084418 K.Prymula, K.SaƂapa, and I.Roterman (2010).
"Fuzzy oil drop" model applied to individual small proteins built of 70 amino acids.
  J Mol Model, 16, 1269-1282.  
19850922 M.Liu, Z.L.Wan, Y.C.Chu, H.Aladdin, B.Klaproth, M.Choquette, Q.X.Hua, R.B.Mackin, J.S.Rao, P.De Meyts, P.G.Katsoyannis, P.Arvan, and M.A.Weiss (2009).
Crystal structure of a "nonfoldable" insulin: impaired folding efficiency despite native activity.
  J Biol Chem, 284, 35259-35272.
PDB code: 3gky
18004974 Z.Y.Guo, Z.S.Qiao, and Y.M.Feng (2008).
The in vitro oxidative folding of the insulin superfamily.
  Antioxid Redox Signal, 10, 127-140.  
17400703 J.V.Nauman, P.G.Campbell, F.Lanni, and J.L.Anderson (2007).
Diffusion of insulin-like growth factor-I and ribonuclease through fibrin gels.
  Biophys J, 92, 4444-4450.  
17081117 E.Glaser, S.Nilsson, and S.Bhushan (2006).
Two novel mitochondrial and chloroplastic targeting-peptide-degrading peptidasomes in A. thaliana, AtPreP1 and AtPreP2.
  Biol Chem, 387, 1441-1447.  
16741994 P.Roche, J.Brown, A.Denley, B.E.Forbes, J.C.Wallace, E.Y.Jones, and R.M.Esnouf (2006).
Computational model for the IGF-II/IGF2r complex that is predictive of mutational and surface plasmon resonance data.
  Proteins, 64, 758-768.  
16864583 Q.X.Hua, J.P.Mayer, W.Jia, J.Zhang, and M.A.Weiss (2006).
The folding nucleus of the insulin superfamily: a flexible peptide model foreshadows the native state.
  J Biol Chem, 281, 28131-28142.  
16728398 Q.X.Hua, M.Liu, S.Q.Hu, W.Jia, P.Arvan, and M.A.Weiss (2006).
A conserved histidine in insulin is required for the foldability of human proinsulin: structure and function of an ALAB5 analog.
  J Biol Chem, 281, 24889-24899.
PDB code: 2h67
15936977 A.Denley, L.J.Cosgrove, G.W.Booker, J.C.Wallace, and B.E.Forbes (2005).
Molecular interactions of the IGF system.
  Cytokine Growth Factor Rev, 16, 421-439.  
15642270 I.Siwanowicz, G.M.Popowicz, M.Wisniewska, R.Huber, K.P.Kuenkele, K.Lang, R.A.Engh, and T.A.Holak (2005).
Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.
  Structure, 13, 155-167.
PDB code: 1wqj
16239223 K.Huang, J.Dong, N.B.Phillips, P.R.Carey, and M.A.Weiss (2005).
Proinsulin is refractory to protein fibrillation: topological protection of a precursor protein from cross-beta assembly.
  J Biol Chem, 280, 42345-42355.  
15501824 Y.Chen, R.Jin, H.Y.Dong, and Y.M.Feng (2004).
In vitro refolding/unfolding pathways of amphioxus insulin-like peptide: implications for folding behavior of insulin family proteins.
  J Biol Chem, 279, 55224-55233.  
14624865 S.Lien, and H.B.Lowman (2003).
Therapeutic peptides.
  Trends Biotechnol, 21, 556-562.  
14573855 X.Y.Jia, Z.Y.Guo, Y.Wang, Y.Xu, S.S.Duan, and Y.M.Feng (2003).
Peptide models of four possible insulin folding intermediates with two disulfides.
  Protein Sci, 12, 2412-2419.  
11983338 K.Deshayes, M.L.Schaffer, N.J.Skelton, G.R.Nakamura, S.Kadkhodayan, and S.S.Sidhu (2002).
Rapid identification of small binding motifs with high-throughput phage display: discovery of peptidic antagonists of IGF-1 function.
  Chem Biol, 9, 495-505.
PDB code: 1lb7
12360255 P.De Meyts, and J.Whittaker (2002).
Structural biology of insulin and IGF1 receptors: implications for drug design.
  Nat Rev Drug Discov, 1, 769-783.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer